BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22278960)

  • 1. The Asp620asn mutation in VPS35 is not a common cause of familial Parkinson's disease.
    Guella I; Soldà G; Cilia R; Pezzoli G; Asselta R; Duga S; Goldwurm S
    Mov Disord; 2012 May; 27(6):800-1. PubMed ID: 22278960
    [No Abstract]   [Full Text] [Related]  

  • 2. Vacuolar protein sorting 35 Asp620Asn mutation is rare in the ethnic Chinese population with Parkinson's disease.
    Zhang Y; Chen S; Xiao Q; Cao L; Liu J; Rong TY; Ma JF; Wang G; Wang Y; Chen SD
    Parkinsonism Relat Disord; 2012 Jun; 18(5):638-40. PubMed ID: 22410496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of the ASP620ASN mutation in VPS35 and Arg1205His mutation in EIF4G1 in familial Parkinson's disease from South Italy.
    Gagliardi M; Annesi G; Tarantino P; Nicoletti G; Quattrone A
    Neurobiol Aging; 2014 Oct; 35(10):2422.e1-2. PubMed ID: 24854799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of VPS35 mutations replicated in French families with Parkinson disease.
    Lesage S; Condroyer C; Klebe S; Honoré A; Tison F; Brefel-Courbon C; Dürr A; Brice A;
    Neurology; 2012 May; 78(18):1449-50. PubMed ID: 22517097
    [No Abstract]   [Full Text] [Related]  

  • 5. VPS35 Asp620Asn and EIF4G1 Arg1205His mutations are rare in Parkinson disease from southwest China.
    Chen Y; Chen K; Song W; Chen X; Cao B; Huang R; Zhao B; Guo X; Burgunder J; Li J; Shang HF
    Neurobiol Aging; 2013 Jun; 34(6):1709.e7-8. PubMed ID: 23261770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in VPS26A are not a frequent cause of Parkinson's disease.
    Koschmidder E; Mollenhauer B; Kasten M; Klein C; Lohmann K
    Neurobiol Aging; 2014 Jun; 35(6):1512.e1-2. PubMed ID: 24417787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D620N mutation in the VPS35 gene and R1205H mutation in the EIF4G1 gene are uncommon in the Greek population.
    Kalinderi K; Bostantjopoulou S; Katsarou Z; Dimikiotou M; Fidani L
    Neurosci Lett; 2015 Oct; 606():113-6. PubMed ID: 26300542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for VPS35 mutations in Parkinson's disease.
    Sheerin UM; Charlesworth G; Bras J; Guerreiro R; Bhatia K; Foltynie T; Limousin P; Silveira-Moriyama L; Lees A; Wood N
    Neurobiol Aging; 2012 Apr; 33(4):838.e1-5. PubMed ID: 22154191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VPS35 Parkinson's disease phenotype resembles the sporadic disease.
    Struhal W; Presslauer S; Spielberger S; Zimprich A; Auff E; Bruecke T; Poewe W; Ransmayr G;
    J Neural Transm (Vienna); 2014 Jul; 121(7):755-9. PubMed ID: 24557499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The VPS35 gene and Parkinson's disease.
    Deng H; Gao K; Jankovic J
    Mov Disord; 2013 May; 28(5):569-75. PubMed ID: 23536430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants.
    Sharma M; Ioannidis JP; Aasly JO; Annesi G; Brice A; Bertram L; Bozi M; Barcikowska M; Crosiers D; Clarke CE; Facheris MF; Farrer M; Garraux G; Gispert S; Auburger G; Vilariño-Güell C; Hadjigeorgiou GM; Hicks AA; Hattori N; Jeon BS; Jamrozik Z; Krygowska-Wajs A; Lesage S; Lill CM; Lin JJ; Lynch T; Lichtner P; Lang AE; Libioulle C; Murata M; Mok V; Jasinska-Myga B; Mellick GD; Morrison KE; Meitnger T; Zimprich A; Opala G; Pramstaller PP; Pichler I; Park SS; Quattrone A; Rogaeva E; Ross OA; Stefanis L; Stockton JD; Satake W; Silburn PA; Strom TM; Theuns J; Tan EK; Toda T; Tomiyama H; Uitti RJ; Van Broeckhoven C; Wirdefeldt K; Wszolek Z; Xiromerisiou G; Yomono HS; Yueh KC; Zhao Y; Gasser T; Maraganore D; Krüger R;
    J Med Genet; 2012 Nov; 49(11):721-6. PubMed ID: 23125461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation of the retromer subunits VPS26A/B-VPS29 in Parkinson's disease.
    Shannon B; Soto-Ortolaza A; Rayaprolu S; Cannon HD; Labbé C; Benitez BA; Choi J; Lynch T; Boczarska-Jedynak M; Opala G; Krygowska-Wajs A; Barcikowska M; Van Gerpen JA; Uitti RJ; Springer W; Cruchaga C; Wszolek ZK; Ross OA
    Neurobiol Aging; 2014 Aug; 35(8):1958.e1-2. PubMed ID: 24684791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VPS35 and EIF4G1 mutations are rare in Parkinson's disease among Indians.
    Sudhaman S; Behari M; Govindappa ST; Muthane UB; Juyal RC; Thelma BK
    Neurobiol Aging; 2013 Oct; 34(10):2442.e1-3. PubMed ID: 23726718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic genetic analysis of the PITX3 gene in patients with Parkinson disease.
    Guo Y; Le WD; Jankovic J; Yang HR; Xu HB; Xie WJ; Song Z; Deng H
    Mov Disord; 2011 Aug; 26(9):1729-32. PubMed ID: 21469209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VPS35 gene variants are not associated with Parkinson's disease in the mainland Chinese population.
    Guo JF; Sun QY; Lv ZY; Yu RL; Li K; Zhang YH; Tian JY; Xia K; Yan XX; Tang BS
    Parkinsonism Relat Disord; 2012 Sep; 18(8):983-5. PubMed ID: 22673036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributions of VPS35 Mutations to Parkinson's Disease.
    Rahman AA; Morrison BE
    Neuroscience; 2019 Mar; 401():1-10. PubMed ID: 30660673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retromer-dependent neurotransmitter receptor trafficking to synapses is altered by the Parkinson's disease VPS35 mutation p.D620N.
    Munsie LN; Milnerwood AJ; Seibler P; Beccano-Kelly DA; Tatarnikov I; Khinda J; Volta M; Kadgien C; Cao LP; Tapia L; Klein C; Farrer MJ
    Hum Mol Genet; 2015 Mar; 24(6):1691-703. PubMed ID: 25416282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VPS35 mutation in Chinese Han patients with late-onset Parkinson's disease.
    Deng H; Xu H; Deng X; Song Z; Zheng W; Gao K; Fan X; Tang J
    Eur J Neurol; 2012 Sep; 19(9):e96-7. PubMed ID: 22891780
    [No Abstract]   [Full Text] [Related]  

  • 19. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease.
    Zimprich A; Benet-Pagès A; Struhal W; Graf E; Eck SH; Offman MN; Haubenberger D; Spielberger S; Schulte EC; Lichtner P; Rossle SC; Klopp N; Wolf E; Seppi K; Pirker W; Presslauer S; Mollenhauer B; Katzenschlager R; Foki T; Hotzy C; Reinthaler E; Harutyunyan A; Kralovics R; Peters A; Zimprich F; Brücke T; Poewe W; Auff E; Trenkwalder C; Rost B; Ransmayr G; Winkelmann J; Meitinger T; Strom TM
    Am J Hum Genet; 2011 Jul; 89(1):168-75. PubMed ID: 21763483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian population.
    Verstraeten A; Wauters E; Crosiers D; Meeus B; Corsmit E; Elinck E; Mattheijssens M; Peeters K; Cras P; Pickut B; Vandenberghe R; Engelborghs S; De Deyn PP; Van Broeckhoven C; Theuns J
    Neurobiol Aging; 2012 Aug; 33(8):1844.e11-3. PubMed ID: 22336192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.